SCHEMBL2524359

SCHEMBL2524359

COc1ccccc1Cc1nc2c(O)ccc(C)c2[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10412619 0.99 — —
SCHEMBL2530644 0.80 PDE9A (0.49) —
Hydrochloric Acid SCHEMBL10411408 0.80 ADRA2A (0.45) —
SCHEMBL10868700 0.80 POLB (0.52) —
SCHEMBL10869577 0.80 TUBB4A (0.47) —
SCHEMBL10411634 0.80 — —
Hydrochloric Acid SCHEMBL10411405 0.79 TUBB4A (0.46) —
Hydrochloric Acid SCHEMBL10411488 0.79 POLB (0.51) —
SCHEMBL2524362 0.78 — —
Hydrochloric Acid SCHEMBL10411490 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048658-A1 FUSED HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED 2010-02-25 — — US claimed
EP-0178413-A1 Benzimidazoles BEECHAM GROUP PLC (GB) 1986-04-23 — — EP claimed
US-8039500-B2 Fused heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-10-18 — — US disclosed
US-20100048658-A1 FUSED HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED 2010-02-25 — — US disclosed
EP-2125753-A1 FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY Takeda Pharmaceutical Company Limited (JP) 2009-12-02 — — EP disclosed
WO-2008082003-A1 FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-10 — — WO disclosed
Send feedback